14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:JUNO
Delisted

Juno Therapeutics Fund Forecast

$86.96
+0 (+0%)
At Close: Mar 28, 2018
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Red day on Wednesday for Juno Therapeutics fund after losing 0%
(Updated on Mar 28, 2018)

Buy or Hold candidate since Feb 01, 2018 Gain 2.33% PDF

No changes to the price of Juno Therapeutics fund on the last trading day (Wednesday, 28th Mar 2018). During the last trading day the fund fluctuated 0% from a day low at $86.96 to a day high of $86.96. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The fund lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the fund is expected to rise 50.01% during the next 3 months and, with a 90% probability hold a price between $115.13 and $168.18 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

JUNO Signals & Forecast

The Juno Therapeutics fund holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $86.96 and $86.55. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, March 27, 2018, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Juno Therapeutics fund

Juno Therapeutics finds support from accumulated volume at $86.64 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the fund tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the fund During the last day, the fund moved $0 between high and low, or 0%. For the last week the fund has had daily average volatility of 0%

Our recommended stop-loss: $83.48 (-4.00%) (This fund has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (JUNO) For The Upcoming Trading Day Of Thursday 29th

For the upcoming trading day on Thursday, 29th we expect Juno Therapeutics to open at $86.96, and during the day (based on 14 day Average True Range), to move between $86.69 and $87.23, which gives a possible trading interval of +/-$0.266 (+/-0.31%) up or down from last closing price. If Juno Therapeutics takes out the full calculated possible swing range there will be an estimated 0.61% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $86.64, some $0.320 (0.37%) from the current price of $86.96, our system finds the risk reward attractive.

Is Juno Therapeutics fund A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Juno Therapeutics fund to perform well in the short-term.

Current score: 2.360 Buy Candidate Unchanged

Predicted Opening Price for Juno Therapeutics of Thursday, March 29, 2018

Fair opening price March 29, 2018 Current price
$86.96 ( 0%) $86.96

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for JUNO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 86.96 .
R2 86.96 .
R1 86.96 .
Current price: 86.96
Support S1 86.96 .
S2 86.96 .
S3 86.96 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 86.96
Support S1 86.64 -0.368%
S2 86.00 -1.10%
S3 69.25 -20.37%

FAQ

What is the symbol for Juno Therapeutics Fund and on which exchange is it traded?
The symbol for Juno Therapeutics is JUNO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Juno Therapeutics Fund?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Juno Therapeutics fund to perform well in the short-term.

How to buy Juno Therapeutics Fund?
Juno Therapeutics Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Juno Therapeutics Fund.

What's the current price of Juno Therapeutics Fund?
As of the end of day on the Mar 28, 2018, the price of an Juno Therapeutics (JUNO) share was $86.96.

What is the 52-week high and low for Juno Therapeutics Fund?
The 52-week high for Juno Therapeutics Fund is $87.01 and the 52-week low is $20.52.
Click to get the best stock tips daily for free!

About Juno Therapeutics

Juno Therapeutics, Inc., a biopharmaceutical company, engages in developing cell-based cancer immunotherapies. The company develops cell-based cancer immunotherapies based on its chimeric antigen receptor and T cell receptor technologies to genetically engineer T cells to recognize and kill cancer cells. Its clinical stage CD19 product candidates include JCAR015 that is in Phase II clinical trials for adult patients with relapsed/refractory B cel... JUNO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT